CCA
TDOC icon

Clearwater Capital Advisors’s Teladoc Health TDOC Stock Holding History

Clearwater Capital Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,178
Closed -$200K – 176
2021
Q4 		$200K Buy
2,178
+65
+3% +$7.77K 0.02% 163
2021
Q3 		$268K Buy
2,113
+251
+13% +$36.5K 0.03% 142
2021
Q2 		$310K Buy
1,862
+386
+26% +$62.5K 0.04% 134
2021
Q1 		$268K Buy
1,476
+297
+25% +$68.9K 0.03% 138
2020
Q4 		$236K Buy
+1,179
New +$240K 0.03% 141
2018
Q2 		– Sell
-500
Closed -$20K – 512
2018
Q1 		$20K Buy
+500
New +$18.9K ﹤0.01% 389

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Clearwater Capital Advisors's TDOC Position: Q1 2022 in Review

Clearwater Capital Advisors sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,178 shares — an estimated $200K sold.

Clearwater Capital Advisors first reported a position in TDOC in Q1 2018 and held it in 6 quarters. The position peaked at $310K in Q2 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Clearwater Capital Advisors reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Clearwater Capital Advisors sold 2,178 Teladoc Health shares in Q1 2022, an estimated $200K.
  • Clearwater Capital Advisors first reported a position in Teladoc Health in Q1 2018 and held it in 6 quarters.
  • Clearwater Capital Advisors's Teladoc Health position peaked at $310K in Q2 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Clearwater Capital Advisors's 13F filing for Q1 2022, filed 3 May 2022.